340B Program Claims Data: How Hospitals Access Pharmacy Dispense Records
Eli Lilly (NYSE: LLY) has conceded defeat in its battle to secure full pharmacy claims data from hospitals under the 340B Drug Pricing Program, bowing to a coordinated boycott that ... Read More